Related Experiment Videos

Differential distribution and expression of Panton-Valentine leucocidin among community-acquired

Battouli Saïd-Salim1, Barun Mathema, Kevin Braughton

  • 1TB Center, Public Health Research Institute, 225 Warren Street, Newark, NJ, 07103, USA.

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is a growing global threat. Research shows Panton-Valentine leucocidin (PVL) isn't solely responsible for CA-MRSA

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) represents a significant and increasing global health concern.
  • CA-MRSA strains exhibit distinct genetic profiles and antibiotic resistance patterns compared to hospital-acquired counterparts.
  • The Panton-Valentine leucocidin (PVL) is frequently found in CA-MRSA and linked to infections, prompting investigation into its pathogenic role.

Purpose of the Study:

  • To genetically characterize CA-MRSA strains and identify distinct clonal families.
  • To investigate the distribution and transcriptional activity of PVL genes in various CA-MRSA strains.
  • To determine the direct impact of PVL on the virulence of CA-MRSA by assessing its effect on human polymorphonuclear leukocytes (PMNs).

Main Methods:

  • Genotyping techniques were employed to define CA-MRSA strains at the genetic level.
  • Analysis of PVL gene distribution and transcription levels across different CA-MRSA isolates.
  • In vitro assays evaluating the lysis of human PMNs upon interaction with PVL-positive and PVL-negative CA-MRSA strains.

Main Results:

  • The prototypic CA-MRSA strain MW2 was identified as a homogeneous clonal family, distinct from other CA-MRSA.
  • PVL genes are variably distributed among CA-MRSA strains but are consistently transcribed when present.
  • No direct correlation was observed between PVL expression levels and the degree of PMN lysis.

Conclusions:

  • PVL is not the sole determinant of leukotoxicity in CA-MRSA pathogenesis.
  • Additional virulence factors likely contribute to the observed leukotoxicity and overall pathogenesis of CA-MRSA.
  • Further research is needed to identify other key virulence factors involved in CA-MRSA infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...